IP78-10: Real-world outcomes of IO-based first-line therapy in metastatic renal cell carcinoma patients on hemodialysis

IP78-10: Real-world outcomes of IO-based first-line therapy in metastatic renal cell carcinoma patients on hemodialysis

Monday, May 18, 2026 7:00 AM to 9:00 AM · 1 hr. 59 min. (America/New_York)
147B
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!